Novartis to Highlight Updated Data from the P-III (NATALEE) Study of Kisqali (Ribociclib) for Treating Early Breast Cancer (EBC) a...
Shots: Novartis will highlight 4yrs. post-hoc analysis from P-III (NATALEE) study...
Neurocrine Biosciences Provides P-II (ERUDITE) Study Updates of Luvadaxistat for Cognitive Impairment Associated with Schizophreni...
Shots: Neurocrine has provided updates on the P-II (ERUDITE) trial assessing the s...
Bayer Reports the P-III (OASIS 3) Trial Data of Elinzanetant to Treat Vasomotor Symptoms in Postmenopausal Women
Shots: Bayer plans to highlight full results from the P-III (
Sanofi Reports the P-III (LIBERTY-CUPID Study C) Trial Data of Dupixent to Treat Chronic Spontaneous Urticaria (CSU)
Shots: The P-III (LIBERTY-CUPID Study C) trial assessed Dupixent + SoC (H1 antihis...
